Key result
Aortic valve replacement with preserved homograft or heterograft in 10 patients resulted in 3 deaths and 3 reoperations, though the authors consider biologic valves as excellent substitutes.
Why the study?
What are the preliminary outcomes of aortic valve replacement using preserved homologous or heterologous biological valves in patients with aortic valvular disease?
Observational (n=10)
What are the preliminary outcomes of aortic valve replacement using preserved homologous or heterologous biological valves in patients with aortic valvular disease?
This early preliminary report demonstrates the initial feasibility but high complication rates of using preserved homologous and heterologous biological valves for aortic valve replacement.
No takes yet. Share an insight, caveat, or question.
High early complications in this small series warrant caution; leaves open durability of preserved biologic valves for larger studies.
Y Senoo (1969) conducted an observational in Aortic valvular disease (n=10). Preserved homograft or heterograft aortic valve replacement was evaluated. Aortic valve replacement with preserved homograft or heterograft in 10 patients resulted in 3 deaths and 3 reoperations, though the authors consider biologic valves as excellent substitutes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: